Physician profile
Kate E Preston
NPI 1265692982
$16,898.57
in general payments reported to CMS, 2019-2025
20 companies · $6,257 in 2025
The $6,257 reported for 2025 was more than what 92% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,648 · 2020: $29.10 · 2021: $408 · 2022: $118 · 2023: $102 · 2024: $6,336 · 2025: $6,257.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $6,000 · Consulting Fee: $4,750 · Travel and Lodging: $1,163 · Food and Beverage: $783.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $6,000.00 |
| Consulting Fee | $4,750.00 |
| Travel and Lodging | $1,162.94 |
| Food and Beverage | $783.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elucent Medical | $12,395.91 | 2021-2025 | |
| Intuitive Surgical, INC. | $3,148.81 | 2019 | |
| Covidien LP | $424.98 | 2019 | |
| Stryker Corporation | $370.58 | 2021-2025 | Molli, Spy-Phi System |
| Tela Bio, INC. | $157.85 | 2019-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Medtronic, INC. | $132.02 | 2021 | |
| Baxter Healthcare | $28.11 | 2024 | |
| Integra Lifesciences Corporation | $27.41 | 2023 | Integra, Integra Dermal Regeneration Template, Surgimend |
| Abbvie INC. | $22.53 | 2025 | |
| Boston Scientific Corporation | $22.02 | 2025 | General - Vascular Intervention |
| 180 Medical, INC. | $19.86 | 2019 | |
| Olympus America INC. | $19.18 | 2024 | Single Use Repositionable Clip |
| Innocoll Pharmaceuticals Limited | $19.18 | 2022 | |
| Dilon Technologies, INC. | $18.47 | 2024 | Hemoblast Bellows |
| Biotissue Holdings INC. | $17.70 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kaleo, INC. | $17.48 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.10 | 2020 | |
| Kci USA, INC. | $14.51 | 2019 | |
| Davol INC. | $12.87 | 2021 | |
| Medtronic USA, INC. | $12.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kate Preston listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.